MUMBAI, India: The world's largest vaccine maker, the Serum Institute of India, has halted production of the locally made version of the AstraZeneca Covid-19 vaccine due to falling demand, its chief executive officer said on Friday.
The Serum Institute has produced more than 1 billion doses of Covishield — its version of the AstraZeneca jab — and is a major supplier to the Covax global inoculation program for poorer countries.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.